Log in to your account:
Gilead Sciences' (GILD) Harvoni Approved in Japan
July 6, 2015 7:05 AM
On Friday, Gilead Sciences (NASDAQ: GILD) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®, the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C
July 3, 2015 2:00 AM